OJC: (2R,3R,3aS,5S,6R,7S,8R,11R,13S,15aR)-2-(6-amino-9H-purin-9-yl)-3,6,7,11,13-pentahydroxyoctahydro-2H,5H,11H,13H-5,8-epoxy-11lambda~5~,13lambda~5~-furo[2,3-g][1,3,5,9,2,4]tetraoxadiphosphacyclotetradecine-11,13-dione
OJC is a Ligand Of Interest in 9P8L designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9P8L_OJC_B_100 | 28% | 12% | 0.216 | 0.873 | 2.21 | 1.77 | 7 | 15 | 1 | 0 | 100% | 1 |
| 9P8L_OJC_A_100 | 27% | 11% | 0.158 | 0.808 | 2.28 | 1.79 | 7 | 14 | 0 | 0 | 100% | 1 |
| 9P8L_OJC_C_100 | 16% | 11% | 0.167 | 0.744 | 2.33 | 1.81 | 7 | 16 | 0 | 0 | 100% | 1 |
| 7UXS_OJC_A_501 | 100% | 71% | 0.03 | 0.991 | 0.39 | 0.59 | - | - | 0 | 0 | 100% | 1 |
| 8SMF_OJC_A_101 | 96% | 18% | 0.053 | 0.97 | 1.62 | 1.77 | 9 | 13 | 0 | 0 | 100% | 1 |
| 8KBE_OJC_B_201 | 94% | 55% | 0.064 | 0.97 | 0.54 | 1.04 | - | 4 | 0 | 0 | 100% | 1 |
| 8SMD_OJC_B_201 | 90% | 13% | 0.067 | 0.955 | 2 | 1.83 | 11 | 13 | 0 | 0 | 100% | 1 |
| 9PTQ_OJC_A_100 | 86% | 17% | 0.07 | 0.944 | 1.85 | 1.68 | 7 | 15 | 0 | 0 | 100% | 1 |
